HFA-ICOS Cardio-Oncology Risk: CML Kinase Inhibitors
TKI cardiotoxicity in CML (educational reference).
Rechner
Erlaeuterung
HFA-ICOS Cardio-Oncology Risk: CML Kinase Inhibitors — educational reference for clinicians and trainees.
Grenzen
Simplified tool; use institutional protocols.
Nur zu Lehrzwecken – nicht fuer Diagnose oder Therapieentscheidungen.